News | April 07, 2024
Bayer and Dr. Reddy's sign marketing and distribution agreement for second brand of Vericiguat in India
Vericiguat works on a pathway not currently targeted by existing heart failure treatments
Vericiguat works on a pathway not currently targeted by existing heart failure treatments
The CRDMO site will add 120,000L manufacturing capacity to WuXi Biologics’ global network
Under the arrangement, Dr. Reddy's will have exclusive rights to promote and distribute Sanofi's vaccine brands Hexaxim, Pentaxim, Tetraxim, Menactra, FluQuadri, Adacel and Avaxim 80U
Centhaquine is a resuscitative agent presently indicated for the treatment of hypovolemic shock by DGCI
The investment will catalyse various components of the IndiaAI Mission
ICMR’s budgetary allowance has increased by 4-fold in the past 10 years, showcasing our commitment towards Health Research
The National One Health Mission will help India to achieve integrated disease control and pandemic preparedness
_Rupak_Singla_256_384.jpg)
Experts discussed the latest innovations, challenges, & collaborative solutions in the fight against TB at NHWIC-2024 held at AIIMS, Delhi
The company's SaaS solutions are tailored to enhance accessibility, efficiency, and patient-centricity in healthcare operations
An accomplished R&D leader and champion of the application of AI to drug discovery
Subscribe To Our Newsletter & Stay Updated
